Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
recruitment failure
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
This is a single-centre, open, parallel-group study with three age groups; no study medication or intervention will be provided. This is a longitudinal follow-up of physiological parameters.
The subjects will be investigated as outpatients. For each subject, 4 individual dates with a duration of approximately 30 minutes each are scheduled - at the end of the first trimenon, at the end of the second trimenon, 4 weeks prior to the calculated date of birth, and 6 weeks after the effective date of birth.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| 1 | 20 to 22 years | ||
| 2 | 30 to 32 years | ||
| 3 | 40 to 42 years |
Not provided
Inclusion Criteria:
Pregnant women without major concomitant disease
Willing and able to provide informed consent
Age (three age groups):
Exclusion Criteria:
Not provided
Not provided
three age groups
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Joachim Siegert, MD, DPharm, Phd | Technische Universität Dresden | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Medizinische Fakultät der Technischen Universität Dresden | Dresden | 01307 | Germany |
Not provided
| ID | Term |
|---|---|
| D009362 | Neoplasm Metastasis |
| ID | Term |
|---|---|
| D009385 | Neoplastic Processes |
| D009369 | Neoplasms |
| D010335 | Pathologic Processes |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
Not provided
Not provided
Not provided